|
Search
Collections
Benchmarks
Upload document
Organization
Xiejingyuan
Rename entity
Add alias
Merge entity
Delete entity
Embed entity
1 clinical trial
Clinical trial
A Randomized, Controlled Clinical Study of Rituximab in Treatment of Primary IgA Nephropathy
Status: Active (not recruiting)
, Estimated PCD: 2023-10-01
